We are monitoring the impact of COVID-19 on Europe Schizoaffective Disorders Treatment Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5957
Share on
Share on

Europe Schizoaffective Disorders Treatment Market Research Report - Segmented By Treatment, By Cause of Disorder, By Type & By Country(UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts | 2019-2024

Pulished: February, 2020
ID: 5957
Pages: 145

Europe Schizoaffective Disorders Treatment Market Size & Growth (2019 - 2024)

As per the research report, the size of the Europe Schizoaffective Disorders Treatment Market is valued at USD xx billion in 2019 and estimated to be growing at a CAGR of xx%, to reach USD xx billion by 2024, during the forecast period 2019-2024.

Schizoaffective Disorder is a mental disorder which is characterized by deregulated emotions and thought processes and. The diagnosis is made when the person has features of both a mood disorder—either bipolar disorder or depression, and schizophrenia but does not meet the diagnostic criteria for either alone strictly. The bipolar type is distinguished by symptoms of hypomania, mania, or mixed episode; the depressive type only by symptoms of depression. Common symptoms of the disorder include paranoid delusions, hallucinations, and disorganized thinking and speech. The onset of symptoms usually begins in young times of adulthood, presently with an uncertain lifetime prevalence since the disorder was redefined in DSM-IV.  Diagnosis is based on the person's reported experiences observed behaviour.

Neurobiology, genetics, early and current environment, social, behavioural, and experiential components appear to be important contributory factors; some prescription and recreational drugs may worsen or cause symptoms. People with schizoaffective disorder are likely to have co-occurring conditions, including substance use disorder and anxiety disorders. Social problems such as long-term unemployment, homelessness and poverty are common. The average life expectancy of people with the disorder is less than those without it, due to rise of problems related to physical health from an absence of health promoting behaviours including a higher suicide rate and a sedentary lifestyle.

The driving factors of Europe Schizoaffective Disorders Treatment market are rapidly rising sedentary life style, increasing healthcare spending, growing prevalence of chronic diseases, availability of advanced healthcare treatments and increasing awareness about schizoaffective disorders. While on the other hand, stringent regulatory approval procedures, social stigma associated with schizoaffective disorders, and lack of diagnosis at right time are some of the factors that are constraining the growth of the Europe schizoaffective disorders treatment market.

This research report segmented and sub-segmented into the following categories:

  • By Treatment: Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy
  • By Cause of Disorder: Genetic Factors, Chemical Factors, Environmental Factors                                                             
  • By Type: Manic Type, Depressive Type, Mixed Type, Schizoaffective Disorders                             
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Europe has the second largest market for schizoaffective disorders treatment by share. Factors such as growing healthcare spending and rising prevalence of chronic diseases is expected to drive the market growth in the region.

Key players operating in the Europe Schizoaffective Disorders Treatment Market profiled in this report are Merz Pharma GmbH & Co. KGaA., Eli Lilliy and Company, Elan Pharmaceuticals, Ciba Pharmaceuticals, Abbott Pharmaceuticals, AstraZeneca plc, and Janssen-Cilag Pty Limited.

1. Introduction         

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods  

                1.4 General Study Assumptions                                                

2. Research Methodology                   

                2.1 Introduction       

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design 

                2.4 Study Timeline  

3. Overview               

                3.1 Executive Summary                                                

                3.2 Key Inferences 

                3.3 Epidemology      

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers  

                4.2 Market Restraints                                                    

                4.3 Key Challenges 

                4.4 Current Opportunities in the Market      

5. Market Segmentation                      

                5.1 Treatment                                                  

                                5.1.1 Antipsychotics                                       







                                5.1.2 Mood Stabilisers                                   




                                5.1.3 Antidepressants                                   





                                5.1.4 Anticonvulsants                                    




                                5.1.5 Psychotherapy                                      

                                       Group Therapy                  

                                       Psychotherapy & Counselling                      


                                5.1.6  Y-o-Y Growth Analysis, By Treatment                                         

                                5.1.7  Market Attractiveness Analysis, By Treatment                                       

                                5.1.8  Market Share Analysis, By Treatment                                        

                5.2 Cause of Disorder                                                    

                                5.2.1 Genetic Factors                                     

                                5.2.2 Chemical Factors                                  

                                5.2.3 Environmental Factors                                       

                                5.2.4 Y-o-Y Growth Analysis, By Cause of Disorder                                           

                                5.2.5 Market Attractiveness Analysis, By Cause of Disorder                                         

                                5.2.6 Market Share Analysis, By Cause of Disorder                                           

                5.3 Type      

                                5.3.1 Manic Type                                             

                                5.3.2 Depressive Type                                   

                                5.3.3 Mixed Type                                            

                                5.3.4 Schizoaffective Disorders                                 

                                5.3.5 Y-o-Y Growth Analysis, By Type                                     

                                5.3.6  Market Attractiveness Analysis, By Type                                  

                                5.3.7  Market Share Analysis, By Type                                    

6. Geographical Analysis                      

                6.1 Introduction       

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                       By Treatment                     

                                       By Cause of Disorder                       

                                       By Type                 

                                6.1.4  Market Attractiveness Analysis                                     

                                       By Treatment                     

                                       By Cause of Disorder                       

                                       By Type                 

                                6.1.5  Market Share Analysis                                      

                                       By Treatment                     

                                       By Cause of Disorder                       

                                       By Type                 

                6.2 U.K                                                 

                6.3 Spain     

                6.4 Germany                                                     

                6.5 Italy       

                6.6 France  

7. Strategic Analysis               

                7.1 PESTLE analysis 

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis      

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                

                8.1 Merz Pharma GmbH & Co. KGaA.                                                     

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Eli Lilliy and Company     

                8.3 Elan Pharmaceuticals      

                8.4 Ciba Pharmaceuticals     

                8.5 Abbott Pharmaceuticals

                8.6 AstraZeneca plc

                8.7 Janssen-Cilag Pty Limited                                                     

9. Competitive Landscape                   

                9.1 Market share analysis    

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures 

                9.4 New Product Launches 

10. Market Outlook and Investment Opportunities                 


                a) List of Tables                                                

                b) List of Figures      

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of region, by Treatmeant along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Schizoaffective Disorders Treatment  Market By Treatment , From 2019-2024 ( USD Million )
  2. Europe Antipsychotics Market By Region, From 2019-2024 ( USD Million )
  3. Europe Mood Stabilisers Market By Region, From 2019-2024 ( USD Million )
  4. Europe Antidepressants Market By Region, From 2019-2024 ( USD Million )
  5. Europe Anticonvulsants  Market By Region, From 2019-2024 ( USD Million )
  6. Europe Psychotherapy Market By Region, From 2019-2024 ( USD Million )
  7. U.K. Schizoaffective Disorders Treatment  Market By Treatment , From 2019-2024 ( USD Million )
  8. Germany Schizoaffective Disorders Treatment  Market By Treatment , From 2019-2024 ( USD Million )
  9. France Schizoaffective Disorders Treatment  Market By Treatment , From 2019-2024 ( USD Million )
  10. Italy Schizoaffective Disorders Treatment  Market By Treatment , From 2019-2024 ( USD Million )
  11. Spain Schizoaffective Disorders Treatment  Market By Treatment , From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample